Functional remodeling of macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma

被引：0
|
作者：
Han, Zhen [1 ,5 ]
Su, Ching-Yu [1 ,5 ]
Wu, Xiwei [2 ,5 ]
Qin, Hanjun [2 ,5 ]
Zain, Jasmine [3 ]
Rosen, Steven T. [3 ,5 ]
Querfeld, Christiane [1 ,3 ,4 ,5 ]
机构：
[1] City Hope Natl Med Ctr, Div Dermatol, Duarte, CA USA
[2] City Hope Natl Med Ctr, Dept Mol & Cellular Biol, Duarte, CA USA
[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] Beckman Res Inst, Duarte, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 156卷
关键词：
Tumor microenvironment; PD1/PD-L1; blockade; lenalidomide; macrophage remodeling; CTCL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Prec-O2-04
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in patients with metastatic cutaneous squamous cell carcinoma.
    Clingan, Philip R.
    Brungs, Daniel
    Arnold, Susan
    Coward, Jermaine
    Fourie, Samuel J.
    Harris, Dean Laurence
    Kurochkin, Andrii
    Ladwa, Rahul
    Malan, Niel
    Mant, Andrew Michael
    McGrath, Margie
    Sharma, Vinay
    Shue, Hong
    Tazbirkova, Andrea
    Oliviero, James
    Desai, Jayesh
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] CD4+T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
    Franken, Amelie
    Bila, Michel
    Mechels, Aurelie
    Kint, Sam
    Van Dessel, Jeroen
    Pomella, Valentina
    Vanuytven, Sebastiaan
    Philips, Gino
    Bricard, Orian
    Xiong, Jieyi
    Boeckx, Bram
    Hatse, Sigrid
    Brussel, Thomas Van
    Schepers, Rogier
    Van Aerde, Cedric
    Geurs, Sarah
    Vandecaveye, Vincent
    Hauben, Esther
    Poorten, Vincent Vander
    Verbandt, Sara
    Vandereyken, Katy
    Qian, Junbin
    Tejpar, Sabine
    Voet, Thierry
    Clement, Paul M.
    Lambrechts, Diether
    IMMUNITY, 2024, 57 (03) : 541 - 558.e7
  • [33] BURN WOUND SEPSIS INDUCED T CELL DYSFUNCTION: ANTI-PD-L1 ANTIBODY IMPROVES SURVIVAL
    Patil, Naeem K.
    Luan, Liming
    Bohannon, Julia K.
    Hernandez, Antonio
    Guo, Yin
    Sherwood, Edward R.
    SHOCK, 2017, 47 (06): : 67 - 68
  • [34] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
    Naidoo, J.
    Page, D. B.
    Li, B. T.
    Connell, L. C.
    Schindler, K.
    Lacouture, M. E.
    Postow, M. A.
    Wolchok, J. D.
    ANNALS OF ONCOLOGY, 2015, 26 (12) : 2375 - 2391
  • [35] The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
    Tunger, Antje
    Sommer, Ulrich
    Wehner, Rebekka
    Kubasch, Anne Sophie
    Grimm, Marc-Oliver
    Bachmann, Michael Philipp
    Platzbecker, Uwe
    Bornhaeuser, Martin
    Baretton, Gustavo
    Schmitz, Marc
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [36] AVAIL-T: A Phase 2a Trial of Avelumab, and Anti-PD-L1 Antibody, in Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL)
    Ahearne, Matthew J.
    Gaskell, Charlotte
    Jackson, Aimee E.
    Morland, Clare
    Hopkins, Louise
    Nawaz, Nadia
    Timmins, Matthew A.
    Fox, Christopher P.
    Collins, Graham P.
    Davies, Andrew
    Lewis, David John
    Cwynarski, Kate
    Linton, Kim
    Mckay, Pam
    Johnson, Rod
    Wagner, Simon D.
    BLOOD, 2020, 136
  • [37] Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
    Banna, Giuseppe Luigi
    Cantale, Ornella
    Bersanelli, Melissa
    Del Re, Marzia
    Friedlaender, Alex
    Cortellini, Alessio
    Addeo, Alfredo
    ONCOLOGY REVIEWS, 2020, 14 (02) : 135 - 143
  • [38] Noninflammatory adjuvant improving dendritic cell priming and anti-PD-L1 efficacy
    Seya, Tsukasa
    Takeda, Yohei
    Matsumoto, Misako
    CANCER SCIENCE, 2018, 109 : 551 - 551
  • [39] Leveraging single B cell technologies in the development of anti-PD-L1 antibodies
    Sencer, Ali Mert
    Gungor, Bilgi
    Kurden-Pekmezci, Asli
    Sayili, Dogu
    Kuyucu, Ayca Zeybek
    Ozgenc, Serhat
    Ulker, Ceren
    Kalyoncu, Sibel
    Inan, Mehmet
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 766 - 766
  • [40] Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
    Puccini, Alberto
    Battaglin, Francesca
    Iaia, Maria Laura
    Lenz, Heinz-Josef
    Salem, Mohamed E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345